Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720

被引:384
|
作者
Allende, ML
Sasaki, T
Kawai, H
Olivera, A
Mi, YD
van Echten-Deckert, G
Hajdu, R
Rosenbach, M
Keohane, CA
Mandala, S
Spiegel, S
Proia, RL
机构
[1] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
[2] NIAMSD, NIH, Bethesda, MD 20892 USA
[3] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany
[4] Virginia Commonwealth Univ, Dept Biochem, Sch Med, Richmond, VA 23298 USA
[5] Merck & Co Inc, Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07065 USA
关键词
D O I
10.1074/jbc.M406512200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine-1-phosphate (S1P), a lipid signaling molecule that regulates many cellular functions, is synthesized from sphingosine and ATP by the action of sphingosine kinase. Two such kinases have been identified, SPHK1 and SPHK2. To begin to investigate the physiological functions of sphingosine kinase and S1P signaling, we generated mice deficient in SPHK1. Sphk1 null mice were viable, fertile, and without any obvious abnormalities. Total SPHK activity in most Sphk1-/- tissues was substantially, but not completely, reduced indicating the presence of multiple sphingosine kinases. S1P levels in most tissues from the Sphk1 -/- mice were not markedly decreased. In serum, however, there was a significant decrease in the S1P level. Although S1P signaling regulates lymphocyte trafficking, lymphocyte distribution was unaffected in lymphoid organs of Sphk1 -/- mice. The immunosuppressant FTY720 was phosphorylated and elicited lymphopenia in the Sphk1 null mice showing that SPHK1 is not required for the functional activation of this sphingosine analogue prodrug. The results with these Sphk1 null mice reveal that some key physiologic processes that require S1P receptor signaling, such as vascular development and proper lymphocyte distribution, can occur in the absence of SPHK1.
引用
收藏
页码:52487 / 52492
页数:6
相关论文
共 50 条
  • [41] THE SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST FTY720 PROMOTES PERIPHERAL NERVE REGENERATION
    Szepanowski, F.
    Derksen, A.
    Hoerste, Meyer Zu G.
    Hartung, H-P
    Kieseier, B. C.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (03) : 282 - 282
  • [42] The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1
    Schmid, Gerald
    Guba, Markus
    Ischenko, Ivan
    Papyan, Armine
    Loka, Mareile
    Schrepfer, Sabine
    Bruns, Christiane J.
    Jauch, Karl-Walter
    Heeschen, Christopher
    Graeb, Christian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (01) : 259 - 270
  • [43] Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation
    Tsai, Hsing-Chuan
    Huang, Yingxiang
    Garris, Christopher S.
    Moreno, Monica A.
    Griffin, Christina W.
    Han, May H.
    JCI INSIGHT, 2016, 1 (09)
  • [44] Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720
    Truong, W.
    Emamaullee, J. A.
    Merani, S.
    Anderson, C. C.
    Shapiro, A. M. James
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (08) : 2031 - 2038
  • [45] Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis (EAE) I. Effect of FTY720 and FTY720-phosphate on myelin proteolipid protein-induced EAE in SJL/J mice
    Kataoka, H.
    Sugahara, K.
    Shimano, K.
    Maeda, Y.
    Koyama, M.
    Fukunari, A.
    Chiba, K.
    8TH INTERNATIONAL CONGRESS OF NEUROIMMUNOLOGY, 2006, : 117 - 120
  • [46] Inhibition of sphingosine 1-phosphate signaling by FTY720 ameliorates murine nonalcoholic steatohepatitis
    Mauer, Amy S.
    Malhi, Harmeet
    HEPATOLOGY, 2016, 64 : 749A - 750A
  • [47] Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
    LaMontagne, K
    Littlewood-Evans, A
    Schnell, C
    O'Reilly, T
    Wyder, L
    Sanchez, T
    Probst, B
    Butler, J
    Wood, A
    Liau, G
    Billy, E
    Theuer, A
    Hla, T
    Wood, J
    CANCER RESEARCH, 2006, 66 (01) : 221 - 231
  • [48] Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
    Mullershausen, Florian
    Craveiro, Luis M.
    Shin, Youngah
    Cortes-Cros, Marta
    Bassilana, Frederic
    Osinde, Maribel
    Wisbart, William L.
    Thallmair, Michaela
    Schwab, Martin E.
    Sivasankaran, Rajeev
    Seuwen, Klaus
    Dev, Kumlesh K.
    JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) : 1151 - 1161
  • [49] The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function
    Sikdar, Sohini
    Mitra, Debmalya
    Das, Oishika
    Bhaumik, Moumita
    Dutta, Shanta
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [50] Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
    Dev, Kumlesh K.
    Mullershausen, Florian
    Mattes, Henri
    Kuhn, Rainer R.
    Bilbe, Graeme
    Hoyer, Daniel
    Mir, Anis
    PHARMACOLOGY & THERAPEUTICS, 2008, 117 (01) : 77 - 93